PCI Biotech: Employee share option scheme Oslo, 2 September 2024 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In...
PCI Biotech first half 2024 interim results Oslo (Norway), 28 August 2024 – PCI Biotech (OSE: PCIB), today announces its interim first half 2024 results. Please find enclosed the interim report...
PCI Biotech: Invitation to first half interim 2024 results presentation Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2024...
Minutes of Annual General Meeting 2024 Oslo, 24 May 2024. The Annual General Meeting in PCI Biotech Holding ASA took place today, 24 May 2024. All the matters on the agenda were approved and the...
Disclosure of voting rights for Chair of the Board Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the...
PCI Biotech Holding ASA - Notice of Annual General Meeting 2024 Oslo, Norway 3 May 2024 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer...
PCI Biotech Holding ASA - Annual Report 2023 Oslo, Norway, April 26, 2024.The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as...
PCI Biotech second half 2023 interim results Oslo (Norway), 14 February 2024 – PCI Biotech (OSE: PCIB), today announces its interim second half 2023 results. Please find enclosed the interim...
PCI Biotech: Invitation to second half interim 2023 results presentation Oslo, Norway, 12 February 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's second half...
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 51 | 51 | 51 | 0 | 0 | DE |
4 | 0 | 0 | 51 | 51 | 51 | 0 | 0 | DE |
12 | 0 | 0 | 51 | 51 | 51 | 0 | 0 | DE |
26 | 0 | 0 | 51 | 51 | 51 | 24 | 51 | DE |
52 | 0 | 0 | 51 | 51 | 51 | 13 | 51 | DE |
156 | 0 | 0 | 51 | 51 | 51 | 860 | 51 | DE |
260 | 0 | 0 | 51 | 51 | 51 | 798 | 51 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales